Qyuns Therapeutics Co., Ltd. is a clinical biopharmaceutical company focusing on biotherapeutics for autoimmune and allergic diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 337 full-time employees. The company went IPO on 2024-03-20. The firm is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The firm's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The firm is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The firm's core products include QX002N and QX005N.
02509.HK stock price ended at $19.8 on 목요일, after dropping 1.98%
On the latest trading day Feb 12, 2026, the stock price of 02509.HK fell by 1.98%, dropping from $20.22 to $19.80. During the session, the stock saw a volatility of 3.69%, with prices oscillating between a daily low of $19.50 and a high of $20.22. On the latest trading day, the trading volume for 02509.HK decreased by 205.8K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 119.4K shares were traded, with a market value of approximately $4.4B.
02509.HK 기술적 시그널
기술적 시그널 요약
구매 신호 1
중립 신호 2
매도 신호 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02509.HK은 현재 1개의 매수 신호와 4개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -6.07%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
02509.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 02509.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.